In vitro, VF-trap blocked VEGF- and bFGF-induced vascular endothelial cell proliferation and migration, while in vivo, combined VEGF and bFGF sequestration resulted in a significant inhibition of renal and lung xenograft tumor growth compared to the single VEGF inhibition [116]. The gene discussed is FGF2; the disease is neoplasm.